{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T15:26:20Z","timestamp":1774020380760,"version":"3.50.1"},"reference-count":33,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2003,7,23]],"date-time":"2003-07-23T00:00:00Z","timestamp":1058918400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2003,8]]},"abstract":"<jats:p><jats:bold>Summary.<\/jats:bold> We determined the <jats:italic>in vitro<\/jats:italic> cellular drug resistance in 370 children with newly diagnosed acute lymphoblastic leukaemia (ALL). The resistance to each of 10 drugs was measured by the fluorometric microculture cytotoxicity assay (FMCA) and was related to clinical outcome. The median follow\u2010up time was 41\u2003months. Risk\u2010group stratified analyses indicated that <jats:italic>in vitro<\/jats:italic> resistance to dexamethasone, doxorubicin and amsacrine were each significantly related to the probability of disease\u2010free survival. In the high\u2010risk (HR) group, increased <jats:italic>in vitro<\/jats:italic> resistance to dexamethasone (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7014), etoposide (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7025) and doxorubicin (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b705) was associated with a worse clinical outcome. Combining the results for these drugs provided a drug resistance score with an independent prognostic significance superior to that of any other factor studied, with a relative risk of relapse in the most resistant group 9\u00b78 times that in the most sensitive group (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7007). The results in the intermediate\u2010risk (IR) and standard\u2010risk (SR) groups were less clear cut. In conclusion, our data indicate that <jats:italic>in vitro<\/jats:italic> testing of cellular drug resistance can be used to predict the clinical outcome in HR ALL, while the final evaluation of the results in IR and SR patients must await longer follow\u2010up.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2003.04442.x","type":"journal-article","created":{"date-parts":[[2003,7,23]],"date-time":"2003-07-23T20:36:09Z","timestamp":1058992569000},"page":"376-385","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Increased <i>in vitro<\/i> cellular drug resistance is related to poor outcome in high\u2010risk childhood acute lymphoblastic leukaemia"],"prefix":"10.1111","volume":"122","author":[{"given":"Britt\u2010Marie","family":"Frost","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Nygren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00f6ran","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Forestier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olafur G.","family":"Jonsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jukka","family":"Kanerva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randi","family":"Nygaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kjeld","family":"Schmiegelow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gudmar","family":"L\u00f6nnerholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"On behalf of the Nordic Society for Paediatric Haematology and Oncology","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,7,23]]},"reference":[{"key":"e_1_2_17_2_1","first-page":"4363","article-title":"In vitro and in vivo killing of acute lymphoblastic leukemia cells by l\u2010asparaginase","volume":"49","author":"Asselin B.L.","year":"1989","journal-title":"Cancer Research"},{"key":"e_1_2_17_3_1","first-page":"a2982","article-title":"Stratification by prednisolone\u2010vincristine\u2010asparginase (PVA) resistance profiles in children with acute lymphoblastic leukemia (ALL) at inital diagnosis","volume":"100","author":"Den Boer M.L.","year":"2002","journal-title":"Blood"},{"key":"e_1_2_17_4_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02153.x"},{"key":"e_1_2_17_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(98)00286-X"},{"key":"e_1_2_17_6_1","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1651-2227.1998.tb00923.x","article-title":"Intensified treatment of acute childhood lymphoblastic leukaemia has improved prognosis, especially in non\u2010high\u2010risk patients: the Nordic experience of 2648 patients diagnosed between 1981 and 1996. Nordic Society of Paediatric Haematology and Oncology (NOPHO)","volume":"87","author":"Gustafsson G.","year":"1998","journal-title":"Acta Paediatrics"},{"key":"e_1_2_17_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401961"},{"key":"e_1_2_17_8_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.560061"},{"key":"e_1_2_17_9_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.d01-3571.x"},{"key":"e_1_2_17_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00051376"},{"key":"e_1_2_17_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900315)65:6<1263::AID-CNCR2820650602>3.0.CO;2-S"},{"key":"e_1_2_17_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.8.2959"},{"key":"e_1_2_17_13_1","first-page":"268","article-title":"Biological characteristics and prognostic value of vitro three\u2010drug resistance to prednisolone, l\u2010asparaginase, and vincristine in childhood acute lymphoblastic leukemia","volume":"70","author":"Hongo T.","year":"1999","journal-title":"International Journal of Hematology"},{"key":"e_1_2_17_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1991.333"},{"key":"e_1_2_17_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.7.2723"},{"key":"e_1_2_17_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/82.7.582"},{"key":"e_1_2_17_17_1","first-page":"249","volume-title":"Drug Resistance in Oncology","author":"Larsson R.","year":"1998"},{"key":"e_1_2_17_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(05)80316-8"},{"key":"e_1_2_17_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910500204"},{"key":"e_1_2_17_20_1","first-page":"1121","article-title":"Feasibility of the fluorometric microculture cytotoxicity assay (FMCA) for cytotoxic drug sensitivity testing of tumor cells from patients with acute lymphoblastic leukemia","volume":"6","author":"Nygren P.","year":"1992","journal-title":"Leukemia"},{"key":"e_1_2_17_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910560517"},{"key":"e_1_2_17_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3835(88)90294-7"},{"key":"e_1_2_17_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1989.44"},{"key":"e_1_2_17_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950220502"},{"key":"e_1_2_17_25_1","first-page":"1712","article-title":"Relationship of the growth of leukemic cells in vitro to the outcome of therapy for acute nonlymphocytic leukemia","volume":"44","author":"Preisler H.D.","year":"1984","journal-title":"Cancer Research"},{"key":"e_1_2_17_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200110000-00002"},{"key":"e_1_2_17_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402144"},{"key":"e_1_2_17_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401977"},{"key":"e_1_2_17_29_1","volume-title":"The basic science of oncology.","author":"Tannock I.","year":"1987"},{"key":"e_1_2_17_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-4811-9_42"},{"key":"e_1_2_17_31_1","first-page":"93","article-title":"Prediction of drug resistance in cancer chemotherapy: the Kern and DiSC assays","volume":"5","author":"Weisenthal L.M.","year":"1991","journal-title":"Oncology (Huntington's)"},{"key":"e_1_2_17_32_1","first-page":"615","article-title":"Clonogenic and nonclonogenic in vitro chemosensitivity assays","volume":"69","author":"Weisenthal L.M.","year":"1985","journal-title":"Cancer Treatment Rep"},{"key":"e_1_2_17_33_1","first-page":"258","article-title":"Comparison of dye exclusion assays with a clonogenic assay in the determination of drug\u2010induced cytotoxicity","volume":"43","author":"Weisenthal L.M.","year":"1983","journal-title":"Cancer Research"},{"key":"e_1_2_17_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1992.5"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2003.04442.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2003.04442.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2003.04442.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T04:17:17Z","timestamp":1697429837000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2003.04442.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7,23]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,8]]}},"alternative-id":["10.1046\/j.1365-2141.2003.04442.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2003.04442.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,7,23]]},"assertion":[{"value":"2003-07-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}